Cargando…
Synthesis and Evaluation of a Series of New Bulleyaconitine A Derivatives as Analgesics
[Image: see text] As a nonaddictive analgesic widely used in clinics, the LD(50) of bulleyaconitine A is just only 0.92 mg/kg, which exhibits obvious toxicity. Therefore, 31 new non-natural C(19)-diterpenoid alkaloids (2a–w, 2′a–e, 3, 4a, and 4b) were designed and synthesized from bulleyaconitine A...
Autores principales: | Zhang, Xing, Shang, Yu-Shan, Gao, Feng, Fang, Dong-Mei, Li, Xiao-Huan, Zhou, Xian-Li |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical Society
2020
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7450621/ https://www.ncbi.nlm.nih.gov/pubmed/32875257 http://dx.doi.org/10.1021/acsomega.0c02944 |
Ejemplares similares
-
Mechanisms for therapeutic effect of bulleyaconitine A on chronic pain
por: Xie, Man-Xiu, et al.
Publicado: (2018) -
Bulleyaconitine A Exerts Antianxiety and Antivisceral Hypersensitivity Effects
por: Huang, Sheng-Nan, et al.
Publicado: (2020) -
Bulleyaconitine A reduces fracture-induced pain and promotes fracture healing in mice
por: Peng, Jun, et al.
Publicado: (2023) -
Molecular signaling underlying bulleyaconitine A (BAA)-induced microglial expression of prodynorphin
por: Li, Teng-Fei, et al.
Publicado: (2017) -
Bulleyaconitine A Effectively Relieves Allergic Lung Inflammation in a Murine Asthmatic Model
por: Zhan, Xiaodong, et al.
Publicado: (2019)